Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,342) with videos related to
Page
of 135
Sort By:
Leukemia & Lymphoma
|
January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Artur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2021
Venetoclax in Previously Treated Waldenström Macroglobulinemia
Jorge J Castillo, John N Allan, Tanya Siddiqi, et al.
Seminars in Hematology
|
April 26, 2023
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia
Ramón Garcia-Sanz, Marzia Varettoni, Cristina Jiménez, et al.
American Journal of Hematology
|
March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia
Jonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
Blood Cancer Journal
|
February 2, 2020
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
Manit Munshi, Xia Liu, Jiaji G Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Loss of tight junction protein claudin 18 uncovers alveolar epithelial stem cell plasticity and emergence of non-fibrogenic transitional progenitors
A Castaldi, J S Chin, B Ma, et al.
British Journal of Haematology
|
December 15, 2015
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia
Lian Xu, Zachary R Hunter, Nicholas Tsakmaklis, et al.
Haematologica
|
November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2024
Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia
Saurabh Zanwar, Jennifer Le-Rademacher, Eric Durot, et al.
The Lancet. Oncology
|
December 14, 2016
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, et al.
Page
of 135
Search research articles
Search
Showing results (1161-1170 of 1,342) with videos related to
Sort By:
Page
of 135
Leukemia & Lymphoma
|
January 5, 2016
Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients
Artur Jurczyszyn, Magdalena Olszewska-Szopa, Vania Hungria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2021
Venetoclax in Previously Treated Waldenström Macroglobulinemia
Jorge J Castillo, John N Allan, Tanya Siddiqi, et al.
Seminars in Hematology
|
April 26, 2023
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia
Ramón Garcia-Sanz, Marzia Varettoni, Cristina Jiménez, et al.
American Journal of Hematology
|
March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia
Jonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
Blood Cancer Journal
|
February 2, 2020
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
Manit Munshi, Xia Liu, Jiaji G Chen, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Loss of tight junction protein claudin 18 uncovers alveolar epithelial stem cell plasticity and emergence of non-fibrogenic transitional progenitors
A Castaldi, J S Chin, B Ma, et al.
British Journal of Haematology
|
December 15, 2015
Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia
Lian Xu, Zachary R Hunter, Nicholas Tsakmaklis, et al.
Haematologica
|
November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemia
Eric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2024
Simplified Risk Stratification Model for Patients With Waldenström Macroglobulinemia
Saurabh Zanwar, Jennifer Le-Rademacher, Eric Durot, et al.
The Lancet. Oncology
|
December 14, 2016
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, et al.
Page
of 135